Trends in Melanoma Phase 3 Clinical Trials since 2010: Is there Hope for Advanced Melanoma Therapies beyond Approved Treatment Mechanisms?

MLA

Hanna H. Kakish, et al. “Trends in Melanoma Phase 3 Clinical Trials since 2010: Is There Hope for Advanced Melanoma Therapies beyond Approved Treatment Mechanisms?” Cancers, vol. 14, no. 21, Sept. 2022. EBSCOhost, widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.doi.dedup.....ad3da9eec15bc8c32479ea63d2603c57&authtype=sso&custid=ns315887.

APA

Hanna H. Kakish, Fasih Ali Ahmed, Mohamedraed Elshami, Alexander W. Loftus, Richard S. Hoehn, John B. Ammori, Lee M. Ocuin, Jordan M. Winter, Jeremy S. Bordeaux, Ankit Mangla, & Luke D. Rothermel. (2022). Trends in Melanoma Phase 3 Clinical Trials since 2010: Is there Hope for Advanced Melanoma Therapies beyond Approved Treatment Mechanisms? Cancers, 14(21).

Chicago

Hanna H. Kakish, Fasih Ali Ahmed, Mohamedraed Elshami, Alexander W. Loftus, Richard S. Hoehn, John B. Ammori, Lee M. Ocuin, et al. 2022. “Trends in Melanoma Phase 3 Clinical Trials since 2010: Is There Hope for Advanced Melanoma Therapies beyond Approved Treatment Mechanisms?” Cancers 14 (21). http://widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.doi.dedup.....ad3da9eec15bc8c32479ea63d2603c57&authtype=sso&custid=ns315887.